Cancer, according to the International
Agency for Research on Cancer (IARC) resulted in the death of around
4.6 million men worldwide in 2012. Around 14% of the world’s total
annual deaths are as a result of various cancers. Modern medicine has
extended the life expectancy of a cancer patient by a great margin.
However newer cases are diagnosed every year globally, the present rate
stands at 7.4 million newly diagnosed males annually, according to the
WHO. This is commonly as a result of the changing lifestyles, unhealthy
diet, hereditary factors and exposure to carcinogenic elements,
cigarette smoking, etc. Male specific cancers include: prostate cancer,
testicular cancer, and penile cancer. Among which prostate cancer is the
most prevalent form of male cancer. Male specific cancers are generally
benign/malignant tumors that rarely undergo metastasis.
Penile cancers are an even rarer form
of cancer specific to the male reproductive organ i.e. penis, but unlike
prostate and testicular cancer, they are commonly as a result of human
papiloma virus (HPV), and human immunodeficiency virus (HIV) infection.
According to the U.S National Cancer Institute study roughly 40% of all
penile cancer is as a result of HPV infections, whereas HIV patients
exhibit eight time increased risk of penile cancer. Hence penile cancer
rates are high in developing countries of Africa, South Asia and South
America. This is probably why vaccination for HPV virus (Gardasil or
Cervarix) is regarded by a share of expert medical practitioners as a
preventive measure in decreasing penile cancer rates globally. The
incidence rate for penile cacner is found higher in men above 30 years
of age, Penile cancer is majorly categorized as squamous cell
carcinoma, as a large majority of penile cancer patients have exhibited
this form. Other even rare types include intraepithelial neoplasia,
bowenoid papulosis and invasive carcinoma of the penis.
The diagnosis of penile cancer is
initially done by physical examination of the penis, this is followed by
the biopsy of the outgrowth i.e. wart/ papules or skin abscess. Staging
of the penile malignancy is done further to establish a timeline of
disease progression. Chemotherapy, antiviral therapy and surgical
excision are the common mode of treatment for penile cancer. Surgical
methods are classified on the type of procedure apt to remove the tumor;
circumcision, microsurgery, excision, or penectomy (castration) are the
generally followed procedures. Radiation is used to prevent any
reoccurrence, although the procedure can render the patient infertile.
That said, the market for male cancer
therapeutics is highly fragmented hence not easily quantifiable, however
the surgery and overall treatment market remains in millions of USD,
with new diagnostic screening procedures and drug combinations being
patented every year, each having their own market segment. With entry of
Asian players the prices too are bound to decrease, thereby potentially
increasing the overall therapeutics market.
To Get Download Full Report with TOC: http://www.mrrse.com/sample/toc/228448
The North American market is the
highest market by volume, followed by Europe, as in these regions the
number of reported cases are high in number, and so is the affordability
of drugs. In developing markets of Asia and South America, their poor
hygiene standards, presence of a large HIV patient population along with
their overall increasing population size make for a large market,
however unavailability of affordable diagnostic procedures and
therapeutic drugs is thought to be the major reason why diagnosis is few
in number and why the markets haven’t been proliferated as of yet. The
rest of the world region is also bound to follow a similar pattern with
increased awareness and diagnostic rates, the number of diagnosed
individuals undergoing therapy in this region is however very small.
Some of the major companies
manufacturing HPV vaccines include: GlaxoSmithKline PLC, Novartis AG,
MercK & Co, etc to name a few.
This research report analyzes this
market on the basis of its market segments, major geographies, and
current market trends. Geographies analyzed under this research report
include :
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive analysis of :
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints.
It provides market projections for the coming years. It includes
analysis of recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing
market players and new entrants along with detailed value chain
analysis.
Reasons for Buying this Report:
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Contact Us
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Toll Free: 866-997-4948
(USA-CANADA)
Tel: +1-518-618-1030
Website: http://www.mrrse.com/
